← Every applicant
Leading FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| FROVATRIPTAN SUCCINATENew drugApr 16, 2025TABLET, ORAL |
| OXAZEPAMNew drugMar 3, 2025CAPSULE, ORAL |
| CARBINOXAMINE MALEATENew drugDec 19, 2024TABLET, ORAL |
| PROCHLORPERAZINE MALEATENew drugSep 30, 2024TABLET, ORAL |
| METYROSINENew drugSep 17, 2024CAPSULE, ORAL |
| KETOROLAC TROMETHAMINENew drugFeb 23, 2023TABLET, ORAL |
| OSELTAMIVIR PHOSPHATENew drugFeb 28, 2022FOR SUSPENSION, ORAL |
| DOXEPIN HYDROCHLORIDENew drugMar 9, 2021CAPSULE, ORAL |